Composites World / NetComposites

Connecting you to the composites industry


NetComposites Ltd has transferred the rights and ownership of this website to Gardner Business Media Inc.

On 1st January 2020, NetComposites' media assets including, newsletters and conferences were transferred to Composites World (Gardner Business Media).

This site is no longer being updated. Please direct all enquiries to

For further details see our joint press release.

Steni UK Increases Warranty on its Composite Rainscreen Cladding Panels to 40 Years

  • Tuesday, 28th May 2013
  • Reading time: about 2 minutes

Composite Rainscreen Cladding manufacturer Steni UK is marking its 50th anniversary of manufacturing with the launch of a 40 year functional warranty.

This has been extended from 25 years on both its Nature and Colour panels, which Steni say allows a modern, dry-trade approach to cladding, and dwarfs the typical guarantees of 10 to 15 years that are offered on traditional render systems.

Steni’s fibreglass reinforced polymer composite panels have been used on a plethora of new-build and renovation projects in the UK, in not just the residential sector but also education, healthcare, retail, leisure and commercial.

Steni’s Nature panels, which feature a surface of aggregated natural stones from Europe, are available in 17 different natural stone colours and up to five grades in many of these colours. In addition, its Colour panels, which feature a smooth surface of 100% acrylic that is electron beam cured without the use of solvents, are available in 44 standard colours and almost any colour from the NCS-, RAL- or BS- system as well as three gloss levels.

Both the Nature and Colour panels are designed to perform for more than 60 years with Steni claiming they are resistant to weather and climate, impact, moisture and water, chemicals, heat and UV light. They also feature excellent fire performance and environment credentials.

Photo provided by Steni UK

For more information visit:

Share this article

More News

Comments (0)

Leave your comment